These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy. Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570 [TBL] [Abstract][Full Text] [Related]
3. Safety of inhalant allergen immunotherapy with mass units-standardized extracts. Nettis E; Giordano D; Pannofino A; Ferrannini A; Tursi A Clin Exp Allergy; 2002 Dec; 32(12):1745-9. PubMed ID: 12653166 [TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites. Song Y; Long J; Wang T; Xie J; Wang M; Tan G J Laryngol Otol; 2018 Mar; 132(3):230-235. PubMed ID: 29374499 [TBL] [Abstract][Full Text] [Related]
5. Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients. Rogala B; Markiewicz-Bendkowska IB; Brzoza Z; Glück J; Oleś E Rhinology; 2007 Jun; 45(2):134-9. PubMed ID: 17708460 [TBL] [Abstract][Full Text] [Related]
6. Local reactions from subcutaneous allergen immunotherapy. Coop CA Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844 [TBL] [Abstract][Full Text] [Related]
7. Side effects during subcutaneous immunotherapy in children with allergic diseases. Tophof MA; Hermanns A; Adelt T; Eberle P; Gronke C; Friedrichs F; Knecht R; Mönter E; Schöpfer H; Schwerk N; Steinbach J; Umpfenbach HU; Weißhaar C; Wilmsmeyer B; Bufe A Pediatr Allergy Immunol; 2018 May; 29(3):267-274. PubMed ID: 29247543 [TBL] [Abstract][Full Text] [Related]
8. [The effectiveness and safety of subcutaneous immunotherapy for inhalable allergens in patients with respiratory allergies]. Valle-Rodríguez F; López-García AI; Rivero-Yeverino D; Caballero-López C; Papaqui-Tapia JS; Ruiz-Márquez IP; Ríos-López JJ; Sánchez-Villalobos JY Rev Alerg Mex; 2019; 66(3):301-307. PubMed ID: 31606013 [TBL] [Abstract][Full Text] [Related]
9. Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey. Bahceci Erdem S; Nacaroglu HT; Karaman S; Unsal Karkıner CS; Gunay I; Dogan D; Asilsoy S; Altınoz S; Can D Int J Pediatr Otorhinolaryngol; 2016 May; 84():55-60. PubMed ID: 27063754 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
11. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study. Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072 [TBL] [Abstract][Full Text] [Related]
12. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study. Asero R Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339 [TBL] [Abstract][Full Text] [Related]
13. [Adverse reactions to skin tests and immunotherapy in the practice of Mexican allergologists]. Larenas Linnemann D; Rodríguez Pérez N; Becerril M Rev Alerg Mex; 2008; 55(2):62-70. PubMed ID: 19058483 [TBL] [Abstract][Full Text] [Related]
14. [New administration routes for immunotherapy]. Martorell Aragonés A Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377 [TBL] [Abstract][Full Text] [Related]
15. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey. Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053 [TBL] [Abstract][Full Text] [Related]
16. Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy. Quiralte J; Justicia JL; Cardona V; Dávila I; Moreno E; Ruiz B; García MA Immunotherapy; 2013 Dec; 5(12):1295-303. PubMed ID: 24283840 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy]. Ibáñez Sendín MD Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375 [TBL] [Abstract][Full Text] [Related]
18. [Adverse reactions to immunotherapy in pediatric patients]. Avila Castañón L; Lerma-Ortiz L; Velázquez Armenta Y; del Rio Navarro BE; Sienra Monge JJ Rev Alerg Mex; 2003; 50(5):182-6. PubMed ID: 14631589 [TBL] [Abstract][Full Text] [Related]